Dietary fat is a lipid source in 2,3,7,8-Tetrachlorodibenzo-ρ-Dioxin (TCDD)-elicited hepatic steatosis in C57BL/6 mice

Toxicological Sciences

Volumn 128, Issue 2, 2012, Pages 377-386

  Angrish, Michelle M ^a   Mets, Bryan D ^b   Jones, Arthur D ^a,b   Zacharewski, Timothy R ^a,b  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b Michigan State University   (United States)

Author keywords

Diet; Metabolic disease; NALFD

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; AROMATIC HYDROCARBON RECEPTOR; LINOLEIC ACID; LINOLENIC ACID; OLEIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARBOHYDRATE INTAKE; CONTROLLED STUDY; FAT INTAKE; FATTY LIVER; FEMALE; LIPID LIVER LEVEL; LIPID TRANSPORT; LIVER WEIGHT; MOUSE; NONHUMAN; NULL ALLELE; PATHOGENESIS;

ANIMALS; BODY WEIGHT; DIETARY FATS; FATTY LIVER; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; GENE EXPRESSION; INTESTINES; LIVER; MICE; MICE, INBRED C57BL; ORGAN SIZE; REAL-TIME POLYMERASE CHAIN REACTION; TETRACHLORODIBENZODIOXIN;

EID: 84865355122     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfs155     Document Type: Article

References (51)

1. Albro, P. W., Corbett, J. T., Harris, M., and Lawson, L. D. (1978). Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on lipid profiles in tissue of the Fischer rat. Chem. Biol. Interact. 23, 315-330.
2. Alexander, D. L., Ganem, L. G., Fernandez-Salguero, P., Gonzalez, F., and Jefcoate, C. R. (1998). Aryl-hydrocarbon receptor is an inhibitory regulator of lipid synthesis and of commitment to adipogenesis. J. Cell Sci. 111(Pt 22), 3311-3322.
3. Angrish, M. M., Jones, A. D., Harkema, J. R., and Zacharewski, T. R. (2011). Aryl hydrocarbon receptor-mediated induction of stearoyl-CoA desaturase 1 alters hepatic fatty acid composition in TCDD-elicited steatosis. Toxicol. Sci. 124, 299-310.
4. Atshaves, B. P., Martin, G. G., Hostetler, H. A., McIntosh, A. L., Kier, A. B., and Schroeder, F. (2010). Liver fatty acid-binding protein and obesity. J. Nutr. Biochem. 21, 1015-1032.
5. Boron, W., and Boulpaep, E. (2008). Medical Physiology. Saunders, Philadelphia, PA.
6. Boverhof, D. R., Burgoon, L. D., Tashiro, C., Sharratt, B., Chittim, B., Harkema, J. R., Mendrick, D. L., and Zacharewski, T. R. (2006). Comparative toxicogenomic analysis of the hepatotoxic effects of TCDD in Sprague Dawley rats and C57BL/6 mice. Toxicol. Sci. 94, 398-416.
7. Burgess, S. C., Leone, T. C., Wende, A. R., Croce, M. A., Chen, Z., Sherry, A. D., Malloy, C. R., and Finck, B. N. (2006). Diminished hepatic gluconeogenesis via defects in tricarboxylic acid cycle flux in peroxisome proliferatoractivated receptor gamma coactivator-1alpha (PGC-1alpha)-deficient mice. J. Biol. Chem. 281, 19000-19008.
8. Denison, M. S., and Nagy, S. R. (2003). Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu. Rev. Pharmacol. Toxicol. 43, 309-334.
9. Denison, M. S., Soshilov, A. A., He, G., DeGroot, D. E., and Zhao, B. (2011). Exactly the same but different: Promiscuity and diversity in the molecular mechanisms of action of the aryl hydrocarbon (dioxin) receptor. Toxicol. Sci. 124, 1-22.
10. Dere, E., Forgacs, A. L., Zacharewski, T. R., and Burgoon, L. D. (2011a). Genome-wide computational analysis of dioxin response element location and distribution in the human, mouse, and rat genomes. Chem. Res. Toxicol. 24, 494-504.
11. Dere, E., Lo, R., Celius, T., Matthews, J., and Zacharewski, T. R. (2011b). Integration of genome-wide computation DRE Search, AhR ChIP-chip and gene expression analyses of TCDD-elicited responses in the mouse liver. BMC Genomics 12, 365.
12. Diani-Moore, S., Ram, P., Li, X., Mondal, P., Youn, D. Y., Sauve, A. A., and Rifkind, A. B. (2010). Identification of the aryl hydrocarbon receptor target gene TiPARP as a mediator of suppression of hepatic gluconeogenesis by 2,3,7,8-tetrachlorodibenzo-p-dioxin and of nicotinamide as a corrective agent for this effect. J. Biol. Chem. 285, 38801-38810.
13. Drover, V. A., Ajmal, M., Nassir, F., Davidson, N. O., Nauli, A. M., Sahoo, D., Tso, P., and Abumrad, N. A. (2005). CD36 deficiency impairs intestinal lipid secretion and clearance of chylomicrons from the blood. J. Clin. Invest. 115, 1290-1297.
14. Forgacs, A. L., Kent, M. N., Makley, M. K., Mets, B., DelRaso, N., Jahns, G. L., Burgoon, L. D., Zacharewski, T. R., and Reo, N. V. (2012). Comparative metabolomic and genomic analyses of TCDD-elicited metabolic disruption in mouse and rat liver. Toxicol. Sci. 125, 41-55.
15. Gertow, K., Pietilainen, K. H., Yki-Jarvinen, H., Kaprio, J., Rissanen, A., Eriksson, P., Hamsten, A., and Fisher, R. M. (2004). Expression of fatty-acid-handling proteins in human adipose tissue in relation to obesity and insulin resistance. Diabetologia 47, 1118-1125.
16. Hankinson, O. (1995). The aryl hydrocarbon receptor complex. Annu. Rev. Pharmacol. Toxicol. 35, 307-340.
17. Hardwick, J. P., Osei-Hyiaman, D., Wiland, H., Abdelmegeed, M. A., and Song, B. J. (2009). PPAR/RXR regulation of fatty acid metabolism and fatty acid omega-hydroxylase (CYP4) isozymes: Implications for prevention of lipotoxicity in fatty liver disease. PPAR Res. 2009, 952734.
18. Hayhurst, G. P., Lee, Y. H., Lambert, G., Ward, J. M., and Gonzalez, F. J. (2001). Hepatocyte nuclear factor 4alpha (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis. Mol. Cell Biol. 21, 1393-1403.
19. Iqbal, J., and Hussain, M. M. (2009). Intestinal lipid absorption. Am. J. Physiol. Endocrinol. Metab. 296, E1183-E1194.
20. Klinge, C. M., Kaur, K., and Swanson, H. I. (2000). The aryl hydrocarbon receptor interacts with estrogen receptor alpha and orphan receptors COUPTFI and ERRalpha1. Arch. Biochem. Biophys. 373, 163-174.
21. Kopec, A. K., Burgoon, L. D., Ibrahim-Aibo, D., Mets, B. D., Tashiro, C., Potter, D., Sharratt, B., Harkema, J. R., and Zacharewski, T. R. (2010). PCB153-elicited hepatic responses in the immature, ovariectomized C57BL/6 mice: Comparative toxicogenomic effects of dioxin and non-dioxin-like ligands. Toxicol. Appl. Pharmacol. 243, 359-371.
22. Kopec, A. K., D'Souza, M. L., Mets, B. D., Burgoon, L. D., Reese, S. E., Archer, K. J., Potter, D., Tashiro, C., Sharratt, B., Harkema J. R., et al. (2011). Non-additive hepatic gene expression elicited by 2,3,7,8-tetrachlorodibenzop-dioxin (TCDD) and 2,2',4,4',5,5'-hexachlorobiphenyl (PCB153) co-treatment in C57BL/6 mice. Toxicol. Appl. Pharmacol. 256, 154-167.
23. Labonte, E. D., Camarota, L. M., Rojas, J. C., Jandacek, R. J., Gilham, D. E., Davies, J. P., Ioannou, Y. A., Tso, P., Hui, D. Y., and Howles, P. N. (2008). Reduced absorption of saturated fatty acids and resistance to diet-induced obesity and diabetes by ezetimibe-treated and Npc1l1-/-mice. Am. J. Physiol. Gastrointest. Liver Physiol. 295, G776-G783.
24. Lakshman, M. R., Campbell, B. S., Chirtel, S. J., and Ekarohita, N. (1988). Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on de novo fatty acid and cholesterol synthesis in the rat. Lipids 23, 904-906.
25. Lakshman, M. R., Ghosh, P., and Chirtel, S. J. (1991) Mechanism of action of 2,3,7,8-tetrachlorodibenzo-p-dioxin on intermediary metabolism in the rat. J. Pharmacol. Exp. Ther. 258, 317-319.
26. Lee, C. C., Yao, Y. J., Chen, H. L., Guo, Y. L., and Su, H. J. (2006). Fatty liver and hepatic function for residents with markedly high serum PCDD/Fs levels in Taiwan. J. Toxicol. Environ. Health A 69, 367-380.
27. Lee, J. H., Wada, T., Febbraio, M., He, J., Matsubara, T., Lee, M. J., Gonzalez, F. J., and Xie, W. (2010). A novel role for the dioxin receptor in fatty acid metabolism and hepatic steatosis. Gastroenterology 139, 653-663.
28. Liu, P. C., and Matsumura, F. (1995). Differential effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on the "adipose-type" and "brain-type" glucose transporters in mice. Mol. Pharmacol. 47, 65-73.
29. Lowes, W., Walker, M., Alberti, K. G., and Agius, L. (1998). Hexokinase isoenzymes in normal and cirrhotic human liver: Suppression of glucokinase in cirrhosis. Biochim. Biophys. Acta 1379, 134-142.
30. Matsumoto, M., Pocai, A., Rossetti, L., Depinho, R. A., and Accili, D. (2007). Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo1 in liver. Cell Metab. 6, 208-216.
31. Mietus-Snyder, M., Sladek, F. M., Ginsburg, G. S., Kuo, C. F., Ladias, J. A., Darnell, J. E., Jr, and Karathanasis, S. K. (1992). Antagonism between apolipoprotein AI regulatory protein 1, Ear3/COUP-TF, and hepatocyte nuclear factor 4 modulates apolipoprotein CIII gene expression in liver and intestinal cells. Mol. Cell Biol. 12, 1708-1718.
32. Miyazaki, M., Kim, Y. C., Gray-Keller, M. P., Attie, A. D., and Ntambi, J. M. (2000). The biosynthesis of hepatic cholesterol esters and triglycerides is impaired in mice with a disruption of the gene for stearoyl-CoA desaturase 1. J. Biol. Chem. 275, 30132-30138.
33. Miyazaki, M., Man, W. C., and Ntambi, J. M. (2001). Targeted disruption of stearoyl-CoA desaturase1 gene in mice causes atrophy of sebaceous and meibomian glands and depletion of wax esters in the eyelid. J. Nutr. 131, 2260-2268.
34. Murray, I. A., Morales, J. L., Flaveny, C. A., Dinatale, B. C., Chiaro, C., Gowdahalli, K., Amin, S., and Perdew, G. H. (2010). Evidence for ligandmediated selective modulation of aryl hydrocarbon receptor activity. Mol. Pharmacol. 77, 247-254.
35. Neeli, I., Siddiqi, S. A., Siddiqi, S., Mahan, J., Lagakos, W. S., Binas, B., Gheyi, T., Storch, J., and Mansbach, C. M., II. (2007). Liver fatty acid-binding protein initiates budding of pre-chylomicron transport vesicles from intestinal endoplasmic reticulum. J. Biol. Chem. 282, 17974-17984.
36. Nguyen, L. P., and Bradfield, C. A. (2008). The search for endogenous activators of the aryl hydrocarbon receptor. Chem. Res. Toxicol. 21, 102-116.
37. Pohjanvirta, R., Sankari, S., Kulju, T., Naukkarinen, A., Ylinen, M., and Tuomisto, J. (1990). Studies on the role of lipid peroxidation in the acute toxicity of TCDD in rats. Pharmacol. Toxicol. 66, 399-408.
38. Pohjanvirta, R., and Tuomisto, J. (1994). Short-term toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in laboratory animals: Effects, mechanisms, and animal models. Pharmacol. Rev. 46, 483-549.
39. Pollenz, R. S., Sattler, C. A., and Poland, A. (1994). The aryl hydrocarbon receptor and aryl hydrocarbon receptor nuclear translocator protein show distinct subcellular localizations in Hepa 1c1c7 cells by immunofluorescence microscopy. Mol. Pharmacol. 45, 428-438.
40. Remillard, R. B., and Bunce, N. J. (2002). Linking dioxins to diabetes: Epidemiology and biologic plausibility. Environ. Health Perspect. 110, 853-858.
41. Romeo, S., Kozlitina, J., Xing, C., Pertsemlidis, A., Cox, D., Pennacchio, L. A., Boerwinkle, E., Cohen, J. C., and Hobbs, H. H. (2008). Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat. Genet. 40, 1461-1465.
42. Simon, T., Cook, V. R., Rao, A., and Weinberg, R. B. (2011). Impact of murine intestinal apolipoprotein A-IV expression on regional lipid absorption, gene expression, and growth. J. Lipid Res. 52, 1984-1994.
43. Smathers, R. L., and Petersen, D. R. (2011). The human fatty acid-binding protein family: Evolutionary divergences and functions. Hum. Genomics 5, 170-191.
44. Storch, J., and McDermott, L. (2009). Structural and functional analysis of fatty acid-binding proteins. J. Lipid Res. 50, S126-S131.
45. Storch, J., and Thumser, A. E. (2010). Tissue-specific functions in the fatty acid-binding protein family. J. Biol. Chem. 285, 32679-32683.
46. Swedenborg, E., Ruegg, J., Makela, S., and Pongratz, I. (2009). Endocrine disruptive chemicals: Mechanisms of action and involvement in metabolic disorders. J. Mol. Endocrinol. 43, 1-10.
47. Vandesompele, J., De Preter, K., Pattyn, F., Poppe, B., Van Roy, N., De Paepe, A., and Speleman, F. (2002). Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 3, 34.
48. Viluksela, M., Unkila, M., Pohjanvirta, R., Tuomisto, J. T.,Stahl, B. U., Rozman, K. K., and Tuomisto, J. (1999). Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on liver phosphoenolpyruvate carboxykinase (PEPCK) activity, glucose homeostasis and plasma amino acid concentrations in the most TCDDsusceptible and the most TCDD-resistant rat strains. Arch. Toxicol. 73, 323-336.
49. Wang, C., Xu, C. X., Krager, S. L., Bottum, K. M., Liao, D. F., and Tischkau, S. A. (2011). Aryl hydrocarbon receptor deficiency enhances insulin sensitivity and reduces PPAR-alpha pathway activity in mice. Environ. Health Perspect. 119, 1739-1744.
50. Watkins, P. A. (2008). Very-long-chain acyl-CoA synthetases. J. Biol. Chem. 283, 1773-1777.
51. Wu, Q., Ortegon, A. M., Tsang, B., Doege, H., Feingold, K. R., and Stahl, A. (2006). FATP1 is an insulin-sensitive fatty acid transporter involved in dietinduced obesity. Mol. Cell Biol. 26, 3455-3467.